API Pharmaceutical Intermediate Lincomycin CAS: 154-21-2 Powder

• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >98%
• Model NO.: HNB-lincomycin
• CAS: 154-21-2
• Molecular Weight: 406.54
• Molecular Formula: C18h34n2o6s
• Einecs: 212-726-7
• Transport Package: Aluminum Foil Bag/Drum
• Specification: 98%
• Trademark: HNB BIOTECH
• Origin: China-Xian

Product Description

            API Pharmaceutical Intermediate Lincomycin CAS:154-21-2 Powder

             Lincomycin is a forest acamide antibiotic produced by Lin Ca, acting on the sensitive bacteria rhythm body, by bonding to the center ring of 50s subunit 23SRRNA gene, preventing the peptide chain from being extended, thereby inhibiting protein synthesis of bacterial cells.

             This product is used for myelitis treatment. Oral applications in response to Staphylococci, Polyvaptic bacteria, pneumococcal, respiratory infection, skin soft tissue infection, female genital road and pelvic infection and anaerobic bacteria Infection, etc. Foreclinomycin injection eliminates the above indications, which can still be used for sepophigenation, bone and joint infection, chronic bone and joint infection, acute blood source bone marrow due to staphylococcus Inflammation, etc. The concentration of Lin Kemycin penetrates into the cerebrospinal fluid cannot reach an effective level, which is not suitable for the treatment of meningitis.
 

Foreign name: lincomycin Molecular formula: C18H34N2O6S Molecular weight: 406.54 CAS login number: 154-21-2 EINECS login number: 205-824-6 Density: 1.17 g / cm3 Melting point: 148 to 150 ° C Boiling point: 646.8 ° C Flashpoint: 345 ° C